SS Innovations International, Inc. (NASDAQ: SSII) has announced a change in its executive leadership with the appointment of Arvind Palaniappan as the interim Chief Financial Officer, effective May 1, 2025. This move comes as part of a planned transition in the company's leadership team, with Anup Sethi, the departing CFO, set to advise the company until a permanent successor is appointed.
Arvind Palaniappan brings over 30 years of experience in accounting and financial management, risk and controls consulting, assurance and compliance, and global business outsourcing process delivery. He is a chartered accountant with the Institute of Chartered Accountants, England and Wales. Prior to his appointment as interim CFO at SS Innovations, Palaniappan served as the principal of Trogon Consulting, a private consulting firm providing outsourced CFO and risk management services to private and public clients.
According to Dr. Sudhir Srivastava, Chairman of the Board and CEO of SS Innovations, Arvind Palaniappan's extensive financial and operations expertise positions him well for a seamless transition into the CFO role.
Anup Sethi, the outgoing CFO, has been recognized for his financial leadership and contributions to SS Innovations over the past seven years, including supporting the launch of more than 80 surgical robotic systems in India and overseas. His tenure saw the company transition from a high-growth start-up to a publicly-traded entity following the uplisting of its common stock to NASDAQ on April 25.
SS Innovations International, Inc. is a developer of innovative surgical robotic technologies aimed at making robotic surgery more affordable and accessible to a global population. The company's product portfolio includes the proprietary "SSI Mantra" surgical robotic system and the comprehensive suite of "SSI Mudra" surgical instruments, designed to support various surgical procedures, including robotic cardiac surgery. Headquartered in India, the company is focused on expanding the global presence of its technologically advanced and cost-effective surgical robotic solutions.
The appointment of Arvind Palaniappan as the interim CFO represents a significant change in the company's leadership and financial management. As SS Innovations continues its search for a permanent successor for the CFO role, the transition is expected to be closely monitored by industry stakeholders and investors. Today the company's shares have moved -2.1% to a price of $10.58. For more information, read the company's full 8-K submission here.
